Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Antimicrobial Agents and Chemotherapy|February 14, 2007
Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimenNils von Hentig, Axel Müller, Carsten Rottmann, et al.
British Journal of Clinical Pharmacology|October 26, 2006
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancyNils von Hentig, Amina Carlebach, Peter Gute, et al.
Medical Microbiology and Immunology|September 18, 2012
Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapyChristoph Stephan, Valentin Bartha, Eva Herrmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patientsMarkus Bickel, Nils von Hentig, Imke Wieters, et al.
AIDS (London, England)|June 19, 2010
Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patientsMarkus Bickel, Imke Wieters, Pavel Khaykin, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2010
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravirMarkus Bickel, Evrim Anadol, Martin Vogel, et al.
Pageof 4